COVID-19 Vaccines: Questions answered by a panel of experts
In partnership with BritCham
COVID-19 Vaccines: Questions answered by a panel of expertsIn partnership with BritCham
The vaccine programme is underway in Hong Kong as a key step towards getting the economy back on its feet and opening borders. However, many residents have been hesitant to participate, and the participation rate is around 5% compared to the target 70% we need for herd immunity. Unanswered questions remain regarding safety, efficacy, effectiveness and more.
We have assembled a panel of two experts: Professor Benjamin Cowling (Division Head at the Division of Epidemiology and Biostatistics, HKUMed) and Dr. David Owens (Specialist in Family Medicine, OT&P), and they will join the Chamber to share their knowledge, expertise and insights on the vaccines, and answer questions from the audience.
This is an opportunity to understand the safety issues, hear more about vaccine effectiveness, and the link between individual and population immunity. The panel will be moderated by Hanif Kanji (Chair of the BritCham's Healthcare Committee).
Webinar access details will be sent via email to registered guests one hour before the event start time.
Please note: The views, thoughts, and opinions expressed by the speaker(s) belong solely to the speaker, and are not representative of the Australian Chamber of Commerce in Hong Kong.
Mon, April 12, 2021
04:30 PM - 05:30 PM
Webinar - Access link will be sent to registered guests one hour ahead of the event
Professor and head of the Division of Epidemiology and Biostatistics | School of Public Health, The University of Hong Kong
Ben Cowling is currently Professor and head of the Division of Epidemiology and Biostatistics in the School of Public Health at the University of Hong Kong, and co-Director of the WHO Collaborating Centre for Infectious Disease Epidemiology and Control. He conducts research into the epidemiology of influenza and other respiratory viruses, with a focus on transmission dynamics and the effectiveness of control measures including vaccination. Since early 2020 he has conducted research on the epidemiology and control of COVID-19 including a series of highly cited publications in NEJM, Science and Nature Medicine. He has authored more than 450 peer-reviewed journal publications to date. He is Editor-in-Chief of Influenza and Other Respiratory Viruses, and an Associate Editor of the journal Emerging Infectious Diseases. His work is supported by a number of major grants from funding bodies in Hong Kong and the United States.
Founding Partner | OT&P Healthcare
Dr. David Owens qualified in the UK and came to Hong Kong in 1987. He is a founding partner of the OT&P medical practice. He is an honorary clinical assistant professor in family medicine Hong Kong University and Chief Medical Officer of the Hong Kong Rugby Union. Since the beginning of the Covid outbreak Dr. Owens has collaborated with the University of Hong Kong on Covid research and has written regular covid updates and produced a number of podcasts with Professor Cowling.
CEO | Sinophi Healthcare
Hanif Kanji is the CEO of Sinophi Healthcare and Chair of the Healthcare Committee.